1. Home
  2. ONMD vs FEMY Comparison

ONMD vs FEMY Comparison

Compare ONMD & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • FEMY
  • Stock Information
  • Founded
  • ONMD 2006
  • FEMY 2004
  • Country
  • ONMD United States
  • FEMY United States
  • Employees
  • ONMD N/A
  • FEMY N/A
  • Industry
  • ONMD
  • FEMY Medical/Dental Instruments
  • Sector
  • ONMD
  • FEMY Health Care
  • Exchange
  • ONMD Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • ONMD 22.2M
  • FEMY 18.6M
  • IPO Year
  • ONMD N/A
  • FEMY 2021
  • Fundamental
  • Price
  • ONMD $0.85
  • FEMY $0.38
  • Analyst Decision
  • ONMD
  • FEMY Strong Buy
  • Analyst Count
  • ONMD 0
  • FEMY 3
  • Target Price
  • ONMD N/A
  • FEMY $7.33
  • AVG Volume (30 Days)
  • ONMD 19.0M
  • FEMY 2.5M
  • Earning Date
  • ONMD 08-13-2025
  • FEMY 08-08-2025
  • Dividend Yield
  • ONMD N/A
  • FEMY N/A
  • EPS Growth
  • ONMD N/A
  • FEMY N/A
  • EPS
  • ONMD N/A
  • FEMY N/A
  • Revenue
  • ONMD $459,000.00
  • FEMY $1,887,016.00
  • Revenue This Year
  • ONMD N/A
  • FEMY $103.55
  • Revenue Next Year
  • ONMD N/A
  • FEMY $148.13
  • P/E Ratio
  • ONMD N/A
  • FEMY N/A
  • Revenue Growth
  • ONMD N/A
  • FEMY 98.61
  • 52 Week Low
  • ONMD $0.30
  • FEMY $0.31
  • 52 Week High
  • ONMD $1.56
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 58.80
  • FEMY 25.97
  • Support Level
  • ONMD $0.82
  • FEMY $0.36
  • Resistance Level
  • ONMD $0.92
  • FEMY $0.42
  • Average True Range (ATR)
  • ONMD 0.10
  • FEMY 0.07
  • MACD
  • ONMD 0.00
  • FEMY -0.01
  • Stochastic Oscillator
  • ONMD 75.81
  • FEMY 18.95

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: